KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Travere Therapeutics (TVTX) Change in Taxes (2016 - 2022)

Historic Change in Taxes for Travere Therapeutics (TVTX) over the last 7 years, with Q4 2022 value amounting to -$22000.0.

  • Travere Therapeutics' Change in Taxes rose 7634.41% to -$22000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $154000.0, marking a year-over-year increase of 10090.06%. This contributed to the annual value of $41000.0 for FY2024, which is 1714.29% up from last year.
  • Per Travere Therapeutics' latest filing, its Change in Taxes stood at -$22000.0 for Q4 2022, which was up 7634.41% from $264000.0 recorded in Q3 2022.
  • In the past 5 years, Travere Therapeutics' Change in Taxes registered a high of $18.8 million during Q1 2020, and its lowest value of -$16.8 million during Q2 2021.
  • Its 4-year average for Change in Taxes is -$128153.8, with a median of -$74000.0 in 2020.
  • Per our database at Business Quant, Travere Therapeutics' Change in Taxes surged by 628026.32% in 2020 and then plummeted by 2256621.62% in 2021.
  • Over the past 4 years, Travere Therapeutics' Change in Taxes (Quarter) stood at -$555000.0 in 2019, then skyrocketed by 735.32% to $3.5 million in 2020, then crashed by 102.64% to -$93000.0 in 2021, then surged by 76.34% to -$22000.0 in 2022.
  • Its Change in Taxes stands at -$22000.0 for Q4 2022, versus $264000.0 for Q3 2022 and -$93000.0 for Q4 2021.